News Alert: Protection against Omicron improves with 3 doses, Pfizer says
  Preliminary lab studies show two doses of the Pfizer/BioNTech vaccine may not provide sufficient protection against the Omicron coronavirus variant, but three doses are able to neutralize it, the companies said in a news release on Wednesday. Samples from people who had two doses of the Covid-19 vaccine saw, on average, a more than 25-fold reduction in neutralization ability against the Omicron variant than the earlier virus, "indicating that two doses of BNT162b2 may not be sufficient to protect against infection with the Omicron variant," the companies said. The companies said two doses may still provide protection against severe disease.  CNN BREAKING NEWS You are receiving this newsletter because you've signed up to receive CNN Breaking News alerts.
No longer want to receive this newsletter? Unsubscribe. Interested in more? See all of our newsletters.
Create CNN Account | Listen to CNN Audio | Download the CNN App
® © 2021 Cable News Network, Inc. A WarnerMedia Company. All Rights Reserved. One CNN Center Atlanta, GA 30303
| ||||||||||||
